Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
Cipla
QuintilesIMS
Federal Trade Commission
Fuji
Moodys
Covington
Express Scripts
Baxter
Colorcon

Generated: August 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 076779

« Back to Dashboard
NDA 076779 describes NICOTINE POLACRILEX, which is a drug marketed by Actavis Labs Ny Inc, Perrigo R And D, Watson Labs, Ivax Sub Teva Pharms, and L Perrigo Co, and is included in thirty-four NDAs. It is available from forty-one suppliers. Additional details are available on the NICOTINE POLACRILEX profile page.

The generic ingredient in NICOTINE POLACRILEX is nicotine polacrilex. There are twenty-nine drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the nicotine polacrilex profile page.

Summary for NDA: 076779

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 076779

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NICOTINE POLACRILEX
nicotine polacrilex
GUM, CHEWING;BUCCAL 076779 ANDA L. Perrigo Company 0113-0532 0113-0532-78 100 BLISTER PACK in 1 CARTON (0113-0532-78) > 1 GUM, CHEWING in 1 BLISTER PACK
NICOTINE POLACRILEX
nicotine polacrilex
GUM, CHEWING;BUCCAL 076779 ANDA Target Corporation 11673-532 11673-532-06 160 BLISTER PACK in 1 CARTON (11673-532-06) > 1 GUM, CHEWING in 1 BLISTER PACK

Summary for product number 001

Active Rx/OTC/Discontinued:OTCDosage:GUM, CHEWING;BUCCALStrengthEQ 4MG BASE
Approval Date:Sep 16, 2004TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
Moodys
QuintilesIMS
McKinsey
Johnson and Johnson
Fish and Richardson
Healthtrust
Merck
Cipla
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot